
pmid: 4712992
Accelerated or malignant hypertension is a progressive vasospastic disease characterized by rapidly increasing peripheral vascular resistance. Arterial pressure must be quickly and effectively reduced to halt arteriolar deterioration and to prevent advancing renal damage, hemorrhagic complications, or hypertensive encephalopathy. In most patients this decrease can be accomplished with a variety of antihypertensive drugs or drug combinations. Only a few cases of accelerated hypertension fail or cease to respond satisfactorily to the commonly employed agents. Such cases have been labeled "refractory" hypertension, and some have been treated with bilateral nephrectomies. Lack of adequate response to the usual antihypertensive drugs should not . . .
Hypertension, Malignant, Vasodilator Agents, Hypertension, Minoxidil, Humans, Vascular Resistance, Diuretics, Propranolol
Hypertension, Malignant, Vasodilator Agents, Hypertension, Minoxidil, Humans, Vascular Resistance, Diuretics, Propranolol
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 24 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
